Related Experiment Video
Updated: Jun 12, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
Is there an association between neurocognitive performance and medication adherence in first episode psychosis?
Martin Lepage1, Michael Bodnar, Ridha Joober
1Douglas Mental Health University Institute and Department of Psychiatry, McGill University, Montréal, Canada. martin.lepage@mcgill.ca
Aim:
Medication adherence is a determining factor for symptomatic remission and relapse prevention following a first episode of psychosis (FEP). Neurocognitive abilities have received only scant attention so far as a risk factor for poor adherence but significant impairments with memory and/or planning abilities could play a role. We examined early medication adherence following admission to a specialized clinical programme for FEP.
Method:
One hundred sixty FEP participants and 35 healthy controls completed an exhaustive neurocognitive assessment. FEP participants were categorized as a function of their medication adherence at 6 months into poor (n = 34), partial (n = 27) and full (n = 99) adherence, respectively. Domain-specific and global measures of cognitive ability were examined.
Results:
No measure of neurocognition could significantly discriminate amongst the three medication adherence groups.
Conclusion:
These results suggest no strong associations between neurocognitive abilities and medication adherence in first episode of psychosis.
Related Concept Videos
Drug Therapy
Antianxiety Medications
Psychosis: Goals of Pharmacotherapy
Psychosis and Antipsychotic Drugs: Overview
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Antipsychotic Drugs: Typical and Atypical Agents
